This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in the Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation: proposals are being requested and a written solicitation will not be issued. This is not a small business set aside. This solicitation number is RFQ2661201 and a solicitation is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005- 60. The National Institutes on Drug Abuse (NIDA) on behalf of the National Institutes on Aging (NIA) has a requirement for Proteomics Assays to include (12) 2DE (DIGE gels including cy dyes); (6) 2DE with silver stain or coomassie blue stain; (12) 2DE data analysis and image analysis; (2) Dephosphorylation experiments; (2)Deglycosylation experiments; (110) MALDI TOF MS gel spots; (12) LC MS MS (LTQ Orbitrao LCMSMS) with data analysis; (12)iTRAQ quantitative Mass Spec determinations; (12) iTRAQ data analysis Offerors will be evaluated on their ability to meet technical specifications. Offerors will also be evaluated on best value in relation to price. Offerors must include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with its offer. Clause at 52.212-4, Contract Terms and Condition Commercial Items, applies to this acquisition. Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition. The quotations are due September 06, 2012 12:00 PM EST and will be submitted electronically to [email protected], Idella Simpson, Contract Specialist, 31 Center Drive, Room 1B59, Bethesda, Maryland 20892.

Bid Protests Not Available